Mayormita, Ronald F.

HRN: 28-69-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2026
CO-AMOXICLAV 625MG (TAB)
03/14/2026
03/20/2026
IV
625mg
TID
Presumptive TB; AGE With Moderate Dehydration
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines